Peter Nurse is a reporter and editor for Investing.com. With a focus on finance and investing, Peter covers a wide range of topics including market trends, economic news, and corporate developments. His articles provide insights and analysis for investors and individuals interested in the financial markets.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Peter's coverage is focused on finance, economy, and investment analysis with a significant portion dedicated to citing data. To effectively reach out to Peter, consider providing in-depth financial data analysis or market insights related to stock markets, global economy trends, currency exchanges, and the impact of geopolitical events on the financial landscape.
As an expert in this field who regularly cites data for his articles, Peter may be interested in receiving pitches that include comprehensive statistical analysis or exclusive access to key economic indicators. Additionally, given his focus on technology companies such as Google and Apple, he might also be receptive to pitches concerning technological developments impacting the business world.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Position added successfully to: In a recent move that has caught the attention of investors, Domo, Inc. (NASDAQ: DOMO ), a leader in
Position added successfully to: Position added successfully to: Position added successfully to: Position added successfully to:
By: Peter Nurse
Investing.com -- The Dow slumped Tuesday, extending its poor start to the second-quarter, pressured by health care stocks and another big jump in Treasury yields amid remarks from several Federal Reserve officials reiterating the need to keep rates higher for longer.
By: Peter Nurse, Ambar Warrick
Position added successfully to: Position added successfully to:
Position added successfully to: Position added successfully to: Position added successfully to: Position added successfully to:
By: Peter Nurse, Louis Juricic
Position added successfully to: Position added successfully to: Position added successfully to: Position added successfully to:
Position added successfully to: Cue Biopharma (NASDAQ: CUE ), Inc., a company focused on pharmaceutical preparations, reported a significant change in its board composition.
Position added successfully to: Zenas BioPharma, Inc. (NASDAQ:ZBIO) director Hongbo Lu has recently made a significant investment in the company's stock.
(833) 317-6278 
